Safety of Alemtuzumab and Autologous Hematopoietic Stem Cell Transplantation Compared to Noninduction Therapies for Multiple Sclerosis

OBJECTIVE: To assess safety outcomes for the induction therapies alemtuzumab and autologous hematopoietic stem cell transplantation (AHSCT) compared to noninduction disease-modifying therapies. METHODS: We performed a population-based cohort study linking the Swedish Multiple Sclerosis Register to n...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neurology
Autori principali: Alping, Peter, Burman, Joachim, Lycke, Jan, Frisell, Thomas, Piehl, Fredrik
Natura: Artigo
Lingua:Inglês
Pubblicazione: Lippincott Williams & Wilkins 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8032381/
https://ncbi.nlm.nih.gov/pubmed/33514645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000011545
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi